摘要
目的：探讨甲胎蛋白（AFP）检测与CT增强扫描在评价肝癌治疗后复发的相关性，为判断肝癌治疗后是否复发寻找依据。方法102例肝癌治疗后复发患者，治疗后1．5～2月做AFP检测与CT增强扫描，分析其对肝癌复发判断的敏感性，及二者的相关性。其中行MR强化23例、PET‐CT 8例、肝动脉造影检查3例，一并进行分析。结果102例肝癌治疗后复发患者均于术后1．5～2月间做血液AFP检测和CT 增强扫描，AFP下降但是未降至正常或较前升高82例，AFP检测敏感性为80．39％（82／102）；CT强化扫描，病灶局部异常强化81例，敏感性为79．41％（81／102）；MR强化23例、PET‐CT 8例、肝动脉造影检查3例，敏感性分别为82．61％、87．5％、100％。结论 AFP检测与CT增强扫描均可评价肝癌治疗后是否复发，A FP检测更敏感，具有方便快捷的优势，应该作为首选的判定肝癌治疗后复发的依据，结合CT增强扫描可提高判断的准确性。
Objective To study the correlation of alpha fetoprotein （AFP） and CT enhanced scan in evaluating the recur‐rence of HCC after treatment and find the foundation for judgment whether recurrence after treatment .Methods 102 pa‐tients with recurrence of HCC after treatment underwent AFP examination and enhanced CT scan after 1 .5-2 months . We analyzed the sensitivity to the recurrence of HCC and the correlation .Ther were 23 cases of enhanced MR ,8 cases of PET‐CT ,3 cases of hepatic angiography .Results 102 patients with recurrence of HCC after treatment were executed AFP test and enhanced CT scan in 1 .5-2 months later .There were 82 cases with AFP decreased but did not drop to nor‐mal or increased .The detection sensitivity of AFP was 80 .39% （82/102）;81 cases of lesions had local enhanced after en‐hanced CT scan ,sensitivity was 79.41% （81/102）;23 cases were subjected to enhanced MR ,8 cases to PET‐CT ,3 cases to hepatic angiography ,the sensitivity was 82 .61% ,87 .5% and 100% respectively .Conclusion AFP examination and enhanced CT scan can evaluate recurrence of HCC after treatment ,AFP examination is more sensitive and has the advanta‐ges of convenient and quick .It should be the preferred method to determine the recurrence of HCC after treatment .It can improve the accuracy of judgment combined with enhanced CT scan .
出处
《医学影像学杂志》
2014年第12期2132-2134,2138,共4页
Journal of Medical Imaging
